Shanghai Pharmaceuticals Holding Co., Ltd SHPMY
$7.24
-$0.15-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 41.27B | 40.47B | 39.31B | 38.77B | 38.30B |
| Total Other Revenue | 166.45M | 144.21M | 144.21M | 147.29M | 155.11M |
| Total Revenue | 41.44B | 40.61B | 39.45B | 38.91B | 38.45B |
| Cost of Revenue | 36.91B | 36.21B | 35.23B | 34.80B | 34.39B |
| Gross Profit | 4.53B | 4.40B | 4.23B | 4.11B | 4.06B |
| SG&A Expenses | 2.78B | 2.74B | 2.63B | 2.58B | 2.51B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 102.94M | 70.33M | 70.37M | 16.44M | -2.48M |
| Total Operating Expenses | 40.13B | 39.35B | 38.26B | 37.72B | 37.21B |
| Operating Income | 1.31B | 1.26B | 1.20B | 1.20B | 1.24B |
| Income Before Tax | 1.24B | 1.42B | 1.36B | 1.34B | 1.39B |
| Income Tax Expenses | 331.55M | 407.21M | 395.35M | 393.53M | 381.02M |
| Earnings from Continuing Operations | 911.89 | 1.01K | 967.24 | 945.63 | 1.01K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -222.29M | -194.39M | -174.07M | -164.65M | -166.11M |
| Net Income | 689.60M | 814.99M | 793.17M | 780.98M | 840.20M |
| EBIT | 1.31B | 1.26B | 1.20B | 1.20B | 1.24B |
| EBITDA | 1.58B | 1.53B | 1.45B | 1.44B | 1.48B |
| EPS Basic | 0.19 | 0.22 | 0.21 | 0.21 | 0.23 |
| Normalized Basic EPS | 0.14 | 0.19 | 0.19 | 0.20 | 0.21 |
| EPS Diluted | 0.19 | 0.22 | 0.21 | 0.21 | 0.23 |
| Normalized Diluted EPS | 0.14 | 0.19 | 0.19 | 0.20 | 0.21 |
| Average Basic Shares Outstanding | 14.83B | 14.83B | 14.83B | 14.77B | 14.83B |
| Average Diluted Shares Outstanding | 14.83B | 14.83B | 14.83B | 14.77B | 14.83B |
| Dividend Per Share | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 |
| Payout Ratio | 60.35% | 52.99% | 49.20% | 50.86% | 58.16% |